News
Glenmark announces the Discovery of a novel chemical entity ‘GRC 17536’, a potential first-in-class molecule globally
Glenmark Pharmaceuticals announced the discovery of a Novel Chemical Entity(NCE) 'GRC 17536'. The new NCE program is targeting TRPA1 recept or antagonists for pain and respiratory disorders. TRPA1 belongs to Transient Receptor Potential(TRP) family of ion channels, which have...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read